Impel Pharmaceuticals Inc.

03/12/2024 | Press release | Distributed by Public on 03/12/2024 06:43

Certificate of Incorporation/Bylaws - Form 8-K

Item 5.03

Amendment to Articles of Incorporation or Bylaws.

Effective as of March 8, 2024, Impel Pharmaceuticals Inc. (the "Company") changed its name to "IPI Legacy Liquidation Co" (the "Name Change") pursuant to a certificate of amendment to its certificate of incorporation (the "Certificate of Amendment"). Pursuant to Section 242(b)(1) of the General Corporation Law of the State of Delaware, the Name Change did not require approval of the Company's stockholders and will not affect the rights of the Company's security holders.

A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 to this Current Report on Form 8-K.